Quantitative determination of 3,4-methylenedioxymethamphetamine by thin-layer chromatography in ecstasy illicit pills in Tehran

被引:6
|
作者
Boushehri, Seyed Vahid Shetab [2 ]
Tamimi, Maryam [1 ]
Kebriaeezadeh, Abbas [1 ]
机构
[1] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacol & Toxicol, Tehran, Iran
[2] Iran Univ Med Sci, Coll Med, Dept Med Nanotechnol, Tehran, Iran
关键词
MDMA; ecstasy illicit pills; TLC; densitometry; scraping off;
D O I
10.3109/15376510903358341
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
3,4-Methylenedioxymethamphetamine (MDMA) is the major ingredient of ecstasy illicit pills. It is a hallucinogen, central nervous system stimulant, and serotonergic neurotoxin that strongly releases serotonin from serotonergic nerves terminals. Moreover, it releases norepinephrine and dopamine from nerves terminal, but to a lesser extent than serotonin. Poisoning and even death from abusing MDMA-containing ecstasy illicit pills among abusers is usual. Thus, quantitative determination of MDMA content of ecstasy illicit pills in illicit drug bazaar must be done regularly to find the most high dose ecstasy illicit pills and removing them from illicit drug bazaar. In the present study, MDMA contents of 13 most abundant ecstasy illicit pills were determined by quantitative thin-layer chromatography (TLC). Two procedures for quantitative determination of MDMA contents of ecstasy illicit pills by TLC were used: densitometric and so-called 'scraping off' methods. The former was done in a reflection mode at 285 nm and the latter was done by absorbance measurement of eluted scraped off spots. Limit of detection (LOD), considering signal-to-noise ratio (S/N) of 2, and limit of quantification (LOQ), regarding S/N of 10, of densitometric and scraping off methods were 0.40 mu g, 1.20 mu g, and 6.87 mu g, 20.63 mu g, respectively. Repeatabilities (within-laboratory error) of densitometric and scraping off methods were 0.5% and 3.6%, respectively. The results showed that the ecstasy illicit pills contained 24-124.5 mg and 23.9-122.2 mg MDMA by densitometric and scraping off methods, respectively.
引用
收藏
页码:565 / 569
页数:5
相关论文
共 50 条
  • [21] GC-FID Optimization and Validation for Determination of 3,4-Methylenedioxymethamphetamine, 3,4-Methylenedioxyamphetamine and Methamphetamine in Ecstasy Tablets
    Phonchai, A.
    Janchawee, B.
    Prutipanlai, S.
    Thainchaiwattana, S.
    JOURNAL OF ANALYTICAL CHEMISTRY, 2010, 65 (09) : 951 - 959
  • [22] Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
    Oeri, Hans Emanuel
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (05) : 512 - 536
  • [23] 3,4-methylenedioxymethamphetamine ("Ecstasy") induces apoptosis of cultured rat liver cells
    Montiel-Duarte, C
    Varela-Rey, M
    Osés-Prieto, JA
    López-Zabalza, MJ
    Beitia, G
    Cenarruzabeitia, E
    Iraburu, MJ
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1588 (01): : 26 - 32
  • [24] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users
    McCann, Una D.
    Edwards, Robert R.
    Smith, Michael T.
    Kelley, Kristen
    Wilson, Michael
    Sgambati, Francis
    Ricaurte, George
    PSYCHOPHARMACOLOGY, 2011, 217 (04) : 475 - 484
  • [25] REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY)
    GREEN, AR
    CROSS, AJ
    GOODWIN, GM
    PSYCHOPHARMACOLOGY, 1995, 119 (03) : 247 - 260
  • [26] Enhanced tau phosphorylation in the hippocampus of mice treated with 3,4-methylenedioxymethamphetamine ("Ecstasy")
    Busceti, Carla L.
    Biagioni, Francesca
    Riozzi, Barbara
    Battaglia, Giuseppe
    Storto, Marianna
    Cinque, Carlo
    Molinaro, Gemma
    Gradini, Roberto
    Caricasole, Andrea
    Canudas, Anna Maria
    Bruno, Valeria
    Nicoletti, Ferdinando
    Fornai, Francesco
    JOURNAL OF NEUROSCIENCE, 2008, 28 (12) : 3234 - 3245
  • [27] Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users
    Una D. McCann
    Robert R. Edwards
    Michael T. Smith
    Kristen Kelley
    Michael Wilson
    Francis Sgambati
    George Ricaurte
    Psychopharmacology, 2011, 217 : 475 - 484
  • [28] Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat
    Upreti, Vijay V.
    Eddington, Natalie D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (04) : 1593 - 1605
  • [29] Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity
    Li, I-Hsun
    Ma, Kuo-Hsing
    Kao, Tzu-Jen
    Lin, Yang-Yi
    Weng, Shao-Ju
    Yen, Ting-Yin
    Chen, Lih-Chi
    Huang, Yuahn-Sieh
    NEUROTOXICOLOGY, 2016, 52 : 114 - 126
  • [30] MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves
    Parrott, AC
    NEUROPSYCHOBIOLOGY, 2004, 50 (04) : 329 - 335